ArticleAntimicrobial agents and chemotherapy2022

Safety, Tolerability, Pharmacokinetics, and Acceptability of Oral and Long-Acting Cabotegravir in HIV-Negative Chinese Men.

Kelong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.